Transforming Big Pharma

Transforming Big Pharma

Transforming Big Pharma

In Transforming Big Pharma John Ansell addresses critically how strategy works in the pharmaceutical industry. The long-standing dearth of new products has led to a growing shortfall in revenues. Ansell assesses the wide range of alternative strategies big pharma companies have been pursuing in recent years in attempting to overcome this. He shows that there is sound evidence to expect the recent upturn in the number of new products reaching the market to go on to greater heights. Chapters assess the complex trends in attrition rates, show how rife spectacular sales underestimation in the industry remains, and explain how conventional wisdom on the chances of product profitability also seriously undersells the industry. The surest route to transforming the prospects for big pharma, Ansell contends, is to step up activity in acquiring and developing new products. This is now realistic because, as he shows, the amount of intellectual property available is much greater than it was a decade ago. Ansell believes that no other strategies have sufficient transformative powers, though they may be useful as a stopgap whilst the sales of forthcoming new products mature. He argues for a reversal of big pharma’s recent cutbacks in R&D and licensing, and re-focussing on new product development. Transforming Big Pharma is intended for those in senior and middle management in the pharmaceutical industry. It will also be valuable to students, as well as to all those dealing with the industry, including biotech companies and those providing services and products to the pharmaceutical industry.

Download now

Product Details:

Genre : Business & Economics
Author : John Ansell
Publisher : CRC Press
Release : 2016-02-24
Total Pages : 284 Pages
ISBN : 9781317007722


Our Daily Meds

Our Daily Meds

In the last thirty years, the big pharmaceutical companies have transformed themselves into marketing machines selling dangerous medicines as if they were Coca-Cola or Cadillacs. They pitch drugs with video games and soft cuddly toys for children; promote them in churches and subways, at NASCAR races and state fairs. They've become experts at promoting fear of disease, just so they can sell us hope. No question: drugs can save lives. But the relentless marketing that has enriched corporate executives and sent stock prices soaring has come with a dark side. Prescription pills taken as directed by physicians are estimated to kill one American every five minutes. And that figure doesn't reflect the damage done as the overmedicated take to the roads. Our Daily Meds connects the dots for the first time to show how corporate salesmanship has triumphed over science inside the biggest pharmaceutical companies and, in turn, how this promotion driven industry has taken over the practice of medicine and is changing American life. It is an ageless story of the battle between good and evil, with potentially life-changing consequences for everyone, not just the 65 percent of Americans who unscrew a prescription cap every day. An industry with the promise to help so many is now leaving a legacy of needless harm.

Download now

Product Details:

Genre : Business & Economics
Author : Melody Petersen
Publisher : Sarah Crichton Books
Release : 2010-07-01
Total Pages : 448 Pages
ISBN : 9781429944038


The Rhetorical Helix Of The Biotechnology And Pharmaceutical Industries

The Rhetorical Helix Of The Biotechnology And Pharmaceutical Industries

"Since the 1980s, the pharmaceutical and biotechnology industries have interacted in a pattern best described as a "helix of rhetorical transformation," with each engaging in a recursive and interactive process of definition, description and ingratiation. The relatively recent emergence of the biotechnology industry has destabilized the older pharmaceutical industry, causing heightened activity of self-evaluation for each, as well as assessment by media, government, economic development agencies, investors, and others. Although the two industries have much in common, their differences have set in motion a rhetorical helix that winds both toward and away from each other. Both industries have foundations built on the modern scientific method and share a mission to develop new drugs for humans and animals. At the same time, they are also made distinct by size (small biotechs versus "big pharma"), relative age, method of drug development (biology-based versus chemistry-based), product capabilities, and characterization of the employee base (innovative and risk-taking versus traditional and risk-averse). In the early 1900s, nascent pharmaceutical companies were keen to shed the image of drug manufacturing as alchemy and adopt a new definition that was grounded in scientific methodology. Public ingratiation soared mid-century with the development of life-saving penicillin but declined toward the end of the century, attributable to several high-profile drug failures as well as charges of excessive profiteering and immoral marketing practices. Meanwhile, public response to biotechnology was rising since the newer industry represented greater potential for transformation--not only of the landscape of drug development, but of communities themselves. The intricacies of the bio-pharma rhetorical helix--including the play between scientistic and dramatistic approaches to language--can be examined by using the framework of dramatism and specifically Kenneth Burke's pentad of key analytical terms. Burke's concepts serve as a systematic form of inquiry for understanding the biotechnology and pharmaceutical meta-narratives (including the mythology associated with Alexander Fleming, Francis Crick, and James Watson) that have emerged within a complex and volatile cultural environment of shifting modernism and postmodernism. They also provide a basis for predicting future constructions of the "biopharmaceutical" drama. George Lakoff's work in metaphor (alone, and in collaboration with Mark Turner and Mark Johnson) is useful in understanding the potent imagery of the double helix, and Ann E. Berthoff's observations of the writing process as a helix speaks to the usefulness of this structure in generating exciting and transformational new meaning."--Abstract from author supplied metadata.

Download now

Product Details:

Genre : Biotechnology
Author : Linda Burak Gretton
Publisher :
Release : 2007
Total Pages : 233 Pages
ISBN : OCLC:176172222


Radical Transformation

Radical Transformation

“Radical Transformation is a tour de force.”– Thomas Homer-Dixon, author of The Upside of Down: Catastrophe, Creativity and the Renewal of Civilization Radical Transformation is a story about industrial civilization’s impending collapse, and about the possibilities of averting this fate. Human communities first emerged as egalitarian, democratic groups that existed in symbiotic relationship with their environments. Increasing complexity led to the emergence of oligarchy, in which societies became captive to the logic of domination, exploitation, and ecological destruction. The challenge facing us today is to build a movement that will radically transform civilization and once more align our evolutionary trajectory in the direction of democracy, equality, and ecological sustainability.

Download now

Product Details:

Genre : Nature
Author : Kevin MacKay
Publisher : Between the Lines
Release : 2018-02-06
Total Pages : 264 Pages
ISBN : 9781771132619


Des Daughters Embodied Knowledge And The Transformation Of Women S Health Politics In The Late Twentieth Century

Des Daughters Embodied Knowledge And The Transformation Of Women S Health Politics In The Late Twentieth Century

From the 1940s to the 1970s, millions of women were exposed prenatally to the synthetic estrogen DES, a “wonder drug” intended to prevent miscarriages. However, DES actually had damaging consequences for the women born from DES mothers. The “DES daughters” as they are known, were found to have a rare form of vaginal cancer or were infertile. They were also at risk for miscarriages, stillbirths, and ectopic pregnancies. In DES Daughters, Susan Bell recounts the experiences of this generation of “victims.” In moving, heartfelt narratives, she presents the voices of those women who developed cancer, those who were cancer-free but have concerns about becoming pregnant, and those who suffered other medical and/or reproductive difficulties. Bell examines the hierarchy of knowledge and power of scientists, doctors, and daughters, tracing the emergence of a feminist health movement. The “embodied knowledge” of these DES daughters prompted them to become advocates and form a social movement that challenged reproductive medical knowledge specifically, but also the politics of women’s health in general. Bell’s important book chronicles the history and future of these grassroots activists born out of illness, suffering, and uncertainty.

Download now

Product Details:

Genre : Health & Fitness
Author : Susan E. Bell
Publisher : Temple University Press
Release : 2009-08-28
Total Pages : 218 Pages
ISBN : 9781592139200


Supply Chain In The Pharmaceutical Industry

Supply Chain In The Pharmaceutical Industry

The pharmaceutical and healthcare industry is hugely complex because it involves so many markets, products, processes and intermediaries. It is also heavily regulated, global, and used by everyone at some stage in their life. No wonder the supply chain for delivery of healthcare services is often fragmented and understood only in discrete sections. Changes in one area impact upon the others, and environmental factors such as pricing, regulatory change or actions by competitors impact the whole supply chain in ways that are not easily understood or managed. Accelerating technology, the commoditization of healthcare, increasing demands from ageing populations all influence the approach that suppliers of pharmaceutical products and services worldwide need to take if they are to design and manage an effective supply chain that will be capable of: exploiting their intellectual property in a sustainable way; providing safe and continuous provision of drugs or devices; and sustaining with resilience, yet still be flexible and cost efficient. Supply Chain in the Pharmaceutical Industry offers the basis for organizations to develop their own blueprint for managing the opportunities and threats to the pharmaceutical supply chain. Using examples from companies and markets across the world Rob Whewell offers a very vivid picture of the developing trends for pharmaceutical companies; the customers and markets they serve and points to some of the elements that underpin sustainable pharmaceutical strategies. The current global banking and financial crisis illustrates the important role played by regulation. The healthcare industry is similar in scope, and complexity, yet the implications of error are worse - life threatening. This review of key industry parameters will provide senior executives in the industry and policy makers in healthcare with a broad perspective of the issues and illustrates an understanding of the task at hand.

Download now

Product Details:

Genre : Business & Economics
Author : Rob Whewell
Publisher : CRC Press
Release : 2016-04-01
Total Pages : 272 Pages
ISBN : 9781317048336


Knowledge Management In The Pharmaceutical Industry

Knowledge Management In The Pharmaceutical Industry

The Pharmaceutical Industry has been undergoing a major transformation since the heady days of 'big pharma' in the 1970s and 80s. Patent expiry, the rise of generics, and the decline of the blockbuster drug have all changed the landscape over the last 10-15 years. It's an environment where products can take 10 years or more to come to market, billions are spent on research and development, jobs are being shed in the western pharma homelands and regulators and the public are more demanding than ever. So what part is Knowledge Management playing and going to play in this vital international industry? Knowledge Management (KM) has many facets from providing comprehensive knowledge bases for workers, through the sharing of advice and problem solving, to providing an environment for innovation and change. This book, focusing on research and development, and manufacturing-based companies, explores how a range of techniques and approaches have been applied in the unique environment of the Pharmaceutical Industry, and examine how it can help the industry in the 21st century. Whilst the book is centered on the Pharmaceutical Industry, its objective will be to discuss and demonstrate how Knowledge Management can be applied in a variety of environments, and with a range of cultural issues. KM practitioners, and potential practitioners, both within and outside the Pharmaceutical Industry, will be able to gain valuable guidance and advice from both the examples of good practice and the lessons learned by the authors and contributors.

Download now

Product Details:

Genre : Business & Economics
Author : Elisabeth Goodman
Publisher : Routledge
Release : 2016-04-22
Total Pages : 204 Pages
ISBN : 9781317108795


Big Science And Research Infrastructures In Europe

Big Science And Research Infrastructures In Europe

This thought-provoking book expands on the notion that Big Science is not the only term to describe and investigate particularly large research projects, scientific collaborations and facilities. It investigates the significant overlap between Big Science and Research Infrastructures (RIs) in a European context since the early twenty-first century. Contributions to this innovative book not only augment the study of Big Science with new perspectives, but also launch the study of RIs as a promising new line of inquiry.

Download now

Product Details:

Genre : Science
Author : Katharina C. Cramer
Publisher : Edward Elgar Publishing
Release : 2020-08-28
Total Pages : 288 Pages
ISBN : 9781839100017


The Workforce Scorecard

The Workforce Scorecard

Executing business strategy with the focus on workforce metrics strategy, a concept building on the HR Scorecard.

Download now

Product Details:

Genre : Business & Economics
Author : Mark A. Huselid
Publisher : Harvard Business Press
Release : 2005
Total Pages : 278 Pages
ISBN : 1591392454


Grand Challenges In Pharmaceutical Medicine Competencies And Ethics In Medicines Development

Grand Challenges In Pharmaceutical Medicine Competencies And Ethics In Medicines Development

Download now

Product Details:

Genre : Science
Author : Honorio Silva
Publisher : Frontiers Media SA
Release : 2021-07-08
Total Pages : Pages
ISBN : 9782889669868